Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Sun, Oct 19, 2025
[Archive]
Volume 16, Issue 4 (Autumn 2025)
Caspian J Intern Med 2025, 16(4): 700-711 |
Back to browse issues page
Ethics code: OPTM/EC/VIBIO/2022
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ganguly A, Banerjee S K, Gubby Venkatesh V, Singal D K, Ganguly A. Molecular signatures of varicosity: Diagnostic insights from ten biomarkers. Caspian J Intern Med 2025; 16 (4) :700-711
URL: http://caspjim.com/article-1-4515-en.html
URL: http://caspjim.com/article-1-4515-en.html
Apurba Ganguly * 
, Sudip Kumar Banerjee , Vidyasagar Gubby Venkatesh , Dinesh kumar Singal , Anondeep Ganguly
, Sudip Kumar Banerjee , Vidyasagar Gubby Venkatesh , Dinesh kumar Singal , Anondeep Ganguly
Department of Biochemistry, Techno India University, Kolkata, India , apurbaganguly15@gmail.com
Abstract: (56 Views)
Background: Varicose veins are a chronic vascular disorder influenced by factors such as inflammation, fibrosis, endothelial dysfunction, and vascular cell activation. This study evaluates the association between ten molecular biomarkers and these risk factors in patients with lower extremity varicosity to enhance understanding of the condition's pathophysiology and highlight potential diagnostic biomarkers.
Methods: A cross-sectional study was conducted involving 126 patients diagnosed with lower extremity varicosity, confirmed by duplex ultrasound, and 108 age- and sex-matched control subjects. Serum levels of ten biomarkers C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and tissue inhibitor of metalloproteinases-1, transforming growth factor-beta 1, procollagen type I N-terminal propeptide, vascular endothelial growth factor, malondialdehyde, endothelin-1, and matrix metalloproteinase-9 were quantified using ELISA. ROC curve analyses assessed the predictive value of these biomarkers.
Results: Patients with varicosity displayed significantly elevated levels of all biomarkers compared to controls, with strong associations to varicosity risk (p < 0.0001). ROC curve analysis revealed high predictive values, with AUCs ranging from 0.858 to 0.939.
Conclusion: The elevated biomarker levels suggest mechanisms including inflammation, fibrosis, endothelial dysfunction, and venous pressure in varicosity. Biomarker monitoring may support early diagnosis and management of varicose veins, enhancing patient outcomes. Future longitudinal studies are advised to further validate these associations.
Methods: A cross-sectional study was conducted involving 126 patients diagnosed with lower extremity varicosity, confirmed by duplex ultrasound, and 108 age- and sex-matched control subjects. Serum levels of ten biomarkers C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and tissue inhibitor of metalloproteinases-1, transforming growth factor-beta 1, procollagen type I N-terminal propeptide, vascular endothelial growth factor, malondialdehyde, endothelin-1, and matrix metalloproteinase-9 were quantified using ELISA. ROC curve analyses assessed the predictive value of these biomarkers.
Results: Patients with varicosity displayed significantly elevated levels of all biomarkers compared to controls, with strong associations to varicosity risk (p < 0.0001). ROC curve analysis revealed high predictive values, with AUCs ranging from 0.858 to 0.939.
Conclusion: The elevated biomarker levels suggest mechanisms including inflammation, fibrosis, endothelial dysfunction, and venous pressure in varicosity. Biomarker monitoring may support early diagnosis and management of varicose veins, enhancing patient outcomes. Future longitudinal studies are advised to further validate these associations.
Keywords: varicose veins, molecular biomarkers, inflammation, endothelial dysfunction, fibrosis, vascular cell activation, elevated venous pressure
Policy Brief: Original Article |
Subject:
Biochimestry
Received: 2024/09/12 | Accepted: 2024/11/26 | Published: 2025/09/18
Received: 2024/09/12 | Accepted: 2024/11/26 | Published: 2025/09/18
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
